PARVULET

Dead / Cancelled — Cancelled — Section 8 (as of 03 May 2019)

What this means for you

This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
78705641
Registration number
4215867
Mark type
Stylized text
Filed
01 Sept 2005
Published for opposition
02 Jun 2009
Registered
02 Oct 2012
Attorney of record
Dianne M. Lambillotte

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations for the treatment of pain relief and pain management, shock, hemorrhage and bleeding, pre- and post-operative complications in the nature of hemorrhage, bleeding, thrombosis, emboli, stroke, apoplexy, lesions, respiratory and circulatory crises and dysfunctions, cognitive dysfunctions, fibrosis, infections, fever and sepsis, and traumas and emergencies, namely, fractures, abrasions, burns, psychological and immunological shock, poisons and pollutions, animal bites or stings, fever, respiratory and cardiovascular shock, crises and dysfunctions, and hemorrhage, bleeding, thrombosis, emboli, stroke, apoplexy, lesions and cognitive dysfunctions, and physical and psychological substance dependence, namely, drug and alcohol dependence, drug tolerance, withdrawal symptoms, convulsions, Alzheimer disease, dementias, Parkinson's disease, insufficient saliva and inability to swallow, allergy/immunology disorders, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases in the nature of flu, AIDS/HIV, anthrax, plague, cholera, biological infections, and prion exposure, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, genitourinary diseases and afflictions, premature labor, poison exposure, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions on the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions, veterinary preparations for the treatment of bovine, sheep, horses, pigs, poultry, ostrich, rodents, dogs, cats, camels, donkeys, elephants; dietetic food adapted for medical use; diagnostic preparations for medical and veterinary use; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; synthetic peptides for pharmaceutical purposes; vitamins; biomedical compounds, namely, peptide substrates for use in analyzing and detecting toxins for medical laboratory use; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets, oral liquids, oral gels, and oral emulsions for the continuous release of a wide variety of therapeutic agents within a certain time after ingestion; medicated candy; medicated chewing gum; breath-freshening chewing gum for medical purposes; medicated lollipops; sweets for medicinal purposes, namely, sweets containing pharmaceutical and medical substances and compounds
  • Class 010 — Medical apparatus: Surgical, medical, dental and veterinary apparatus and instruments, namely, drug delivery apparatus and instruments in the form of containers for various pharmaceuticals, drugs, medicines, compounds and substances in the form of liquids, gels, grains, emulsions, blister packs and sachets; spoons, cups and syringes for administering pharmaceutical substances and medicines; drug delivery systems
  • Class 040 — Treatment of materials: Treatment of materials, namely, milling, mixing, grinding, liquefying, pulverizing, melting and extrusion of medical and pharmaceutical substances, compounds and materials
  • Class 042 — Scientific and technological services: Scientific research; technology consultation in the field of scientific research; design for others in the fields of pain relief and pain management, pharmaceutical drug and medicine development, development of medicines and medicine goods and packaging in the fields of traumas and emergencies, addictions, aging, allergy/immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical- and gynecological field, occupational diseases and afflictions, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear-nose and throat, diseases and afflictions on the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions, veterinary preparations for the treatment of bovine, sheep, horses, pigs, poultry, ostrich, rodents, dogs, cats, camels, donkeys, elephants; chemical, biochemical, biological and bacteriological research and analysis; pharmaceutical drug and medicine development services; design for others in the field of drugs and medicines; development of pharmaceutical preparations and medicines; professional consultancy pertaining to pharmacology, namely, biotechnical and biomedical and medical and pharmaceutical substances, preparations and compounds; professional consultancy in the field of research and development of medicine and the dispensing of pharmaceutical preparations; pharmaceutical drug development services comprised of scientific, industrial, technological, bio technical, pharmaceutical, biomedical and clinical research in the field of drugs and drug candidates; medical and scientific research, namely, conducting clinical trials of new drug candidates; consultation in the field of scientific research pertaining to chemical, pharmaceutical and medical goods; design for others in the field of medical packaging and equipment; development of pharmaceutical preparations and medicines; consultation in the field of biotechnological and biomedical scientific research; biochemical and molecular biological analyses; in vitro and in vivo preclinical tests and clinical tests of drug candidates and potential drugs; consultancy and research regarding pharmaceuticals in gel-like and viscous liquid dosage forms; consultancy and research pertaining to pharmacology in the nature of alternative drugs for the young, elderly and those with difficulties swallowing pills and tablets; development of in vitro and in vivo preclinical tests of drug candidates and potential drugs; biochemical and molecular biological analyses; scientific, industrial, technological and biotechnological analysis in the field of pharmaceutical and veterinary drug and medicine analysis, analysis of drug delivery apparatus and containers, analysis of synthetic peptides for pharmaceutical purposes, analysis of peptide substrates, analysis for the purpose of detecting various toxins, analysis of drug candidates and potential drugs

Owner

Prosecution history

  • 31 Jul 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 03 May 2019 — CANCELLED SEC. 8 (6-YR)
  • 02 Oct 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 14 Sept 2016 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 14 Sept 2016 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 02 Oct 2012 — REGISTERED-PRINCIPAL REGISTER
  • 29 Aug 2012 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
  • 15 Aug 2012 — NOTICE OF ALLOWANCE CANCELLED
  • 15 Aug 2012 — TEAS DELETE 1(B) BASIS RECEIVED
  • 22 Feb 2012 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 21 Feb 2012 — SOU EXTENSION 5 GRANTED
  • 10 Feb 2012 — SOU EXTENSION 5 FILED
  • 10 Feb 2012 — SOU TEAS EXTENSION RECEIVED
  • 23 Aug 2011 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 20 Aug 2011 — SOU EXTENSION 4 GRANTED

View this trademark record on Marksy